Characterisation of the Novel HLA‐DPB1*1781:01 Allele Using Oxford Nanopore Sequencing Technology
HLA · 2025
DOI: 10.1111/tan.70142 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Jizhi Wen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Alleles, HLA-DP beta-Chains, Nanopore Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben. Gefördert von: Science and Technology Projects in Guangzhou, the Key Medical Disciplines and Specialties Program of Guangzhou (2025-2027).
Abstract (Originalsprache)
HLA‐DPB1*1781:01 differs from HLA‐DPB1*03:01:01:01 by one nonsynonymous nucleotide substitution in codon 5 in exon 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China.
- The Key Medical Laboratory of Guangzhou, Guangzhou, China.
Förderung
- Science and Technology Projects in Guangzhou
- the Key Medical Disciplines and Specialties Program of Guangzhou (2025-2027)
Zitieren
APA
Wen, J., Ding, H., Wei, L., Jia, S., & Ji, Y. (2025). Characterisation of the Novel HLA‐DPB1*1781:01 Allele Using Oxford Nanopore Sequencing Technology. HLA. https://doi.org/10.1111/tan.70142
Vancouver
Wen J, Ding H, Wei L, Jia S, Ji Y. Characterisation of the Novel HLA‐DPB1*1781:01 Allele Using Oxford Nanopore Sequencing Technology. HLA. 2025. doi:10.1111/tan.70142
BibTeX
@article{Wen2025,
author = {Wen, Jizhi and Ding, Haoqiang and Wei, Ling and Jia, Shuangshuang and Ji, Yanli},
title = {Characterisation of the Novel HLA‐DPB1*1781:01 Allele Using Oxford Nanopore Sequencing Technology},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70142}
}
EUVIMED